<DOC>
	<DOCNO>NCT02344394</DOCNO>
	<brief_summary>The overall objective study compare assess clinical outcome standard care hybrid ablation use epicardial ablation conjunction endocardial PVI alone versus epicardial ablation conjunction endocardial ablation use PVI additional RF ablation randomize , prospective population patient persistent AF least 6 month duration . All device use utilized approve labeling device .</brief_summary>
	<brief_title>Comparison Hybrid Ablation Pulmonary Vein Isolation Alone v Hybrid Ablation With PVI Plus Catheter Ablation</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) one lead cause stroke heart failure . It also major cause hospitalization mortality ( Stewart , Wattigney , Wolf ) . Patients atrial fibrillation ( AF ) intolerant Class I III antiarrhythmic drug often require endocardial ablation , include pulmonary vein isolation ( PVI ) use radiofrequency ( RF ) catheter ablation cryoballoon ablation ( Medtronic , MN ) report success rate vary ( Calkins et al ) . In patient persistent long stand persistent AF success rate may high ( Akoum et al ) little data analyze outcomes patient population ( Calkins et al ) . Using epicardial-endocardial , hybrid , approach Gehi et al describes 66 % 12 month arrythmia-free survival rate follow procedure , 37 % patient still antiarrythmic drug therapy 12 month . Furthermore , paper Anderson et al report hybrid ablation result low cost high quality adjust life year patient non-paroxysmal AF report studie 's result few repeat ablation maintenance sinus rhythm 5 year . Conflicting report exist much endocardial catheter ablation need patient persistent long stand persistent AF . Verma et al report result patient persistent AF endocardial PVI compare P VI plus additional linear lesion . Eighteen month success rate patient 59 % 46 % respectively . Success surgical hybrid ablation use epicardial ablation cocontaminent endocardial PVI alone versus hybrid approach use epicardial ablation endocardial ablation consist PVI ablation RF ablation study use randomize , prospective approach . If find PVI alone effective PVI plus additional catheter ablation patient receive hybrid ablation , may reduce need extensive catheter ablation , thereby reduce radiation exposure , procedure time , radiofrequency ablation time .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>The subject 18 year age old Left atrium &lt; 6.0 em ( Trans Thoracic Echo TTE parasternal4 chamber view perform within 6 month ) History AF least 6 month Failed refractory one AAD ( class I and/or Ill ) Documentation persistent AF Provided write informed consent Be eligible hybrid procedure Pregnant planning become pregnant study Comorbid medical condition limit one year life expectancy Previous cardiac surgery Previous abdominal surgery prevent epicardial access History pericarditis Previous cerebrovascular accident ( CVA ) , exclude fully resolve TIA Patients active infection sepsis Patients esophageal ulcer stricture varix Patients renal dysfunction dialysis ( define GFR : :5 40 ) Patients contraindicated anticoagulant heparin coumadin Patients treat ventricular arrhythmia Patients previous leave atrial catheter ablation AF ( include ablation AFL supraventricular arrhythmia ) Current participation another clinical investigation medical device drug , recent participation study within 30 day prior study enrollment Not competent legally represent ( e.g. , require guardian caretaker legal representative )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Anti-Arrhythmia Agents</keyword>
	<keyword>Catheter Ablation</keyword>
	<keyword>surgical hybrid ablation</keyword>
</DOC>